Table 1 Antibacterial screening for compounds (4a-q).
Diameter of inhibition zone (mm) | ||||||
|---|---|---|---|---|---|---|
Cpd | Gram + ve bacteria | Gram –ve bacteria | ||||
S. Aureus (MRSA) | S. aureus | B. subtilis | B. cereus | E. coli | K. pneumonia | |
4a | 14 | 0 | 0 | 13 | 11 | 14 |
4b | 13 | 0 | 0 | 14 | 12 | 13 |
4c | 15 | 0 | 0 | 17 | 12 | 13 |
4d | 12 | 0 | 0 | 15 | 0 | 12 |
4e | 12 | 0 | 0 | 14 | 0 | 10 |
4f | 12 | 0 | 8 | 15 | 0 | 9 |
4g | 17 | 23 | 21 | 20 | 14 | 16 |
4h | 13 | 9 | 0 | 9 | 0 | 10 |
4i | 13 | 0 | 0 | 8 | 0 | 14 |
4j | 13 | 0 | 0 | 8 | 12 | 14 |
4k | 12 | 0 | 0 | 0 | 13 | 15 |
4l | 13 | 0 | 0 | 8 | 0 | 14 |
4m | 14 | 0 | 0 | 13 | 10 | 13 |
4n | 14 | 0 | 0 | 13 | 0 | 11 |
4o | 12 | 10 | 0 | 14 | 12 | 11 |
4p | 13 | 11 | 0 | 15 | 11 | 12 |
4q | 13 | 10 | 10 | 13 | 12 | 13 |
Ciprofloxacin | 0 | 0 | 0 | 22 | 25 | 0 |
DMSO | 0 | 0 | 0 | 0 | 0 | 0 |
